{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T08:27:15Z","timestamp":1769243235840,"version":"3.49.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Veterinary Science"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.rvsc.2017.12.005","type":"journal-article","created":{"date-parts":[[2017,12,15]],"date-time":"2017-12-15T12:52:30Z","timestamp":1513342350000},"page":"125-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Comparison of conventional and lipid emulsion formulations of amphotericin B: Pharmacokinetics and toxicokinetics in dogs"],"prefix":"10.1016","volume":"117","author":[{"given":"J.","family":"Nieto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Alvar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.I.","family":"San Andr\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.D.","family":"San Andr\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rvsc.2017.12.005_bb0005","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1128\/AAC.41.10.2201","article-title":"Pharmacokinetics profile of ABELCET (amphotericin B lipid complex injection): combined experience from phase I and phase II studies","volume":"41","author":"Adedoyin","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0010","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1177\/106002809502900509","article-title":"Amphotericin B toxicity reduced by administration in fat emulsion","volume":"29","author":"Anderson","year":"1995","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0030","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/bdd.2510150606","article-title":"The penetration of amphotericin B from an Intralipid\u00ae formulation into fibrin loci in a rabbit model of candidiasis","volume":"15","author":"Bouley","year":"1994","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0035","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/BF01989977","article-title":"Clinical evaluation of a new lipid-based delivery system for intravenous administration of amphotericin B","volume":"11","author":"Caillot","year":"1992","journal-title":"Eur. J. Clin. Microbiol."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0040","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jac\/31.1.161","article-title":"Efficacy and tolerance of an amphotericin B lipid (Intralipid) emulsion in the treatment of candidaemia in neutropenic patients","volume":"31","author":"Caillot","year":"1993","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0045","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1136\/bmj.305.6859.921","article-title":"Trial of glucose versus fat emulsion in preparation of amphotericin for use in HIV infected patients with candidiasis","volume":"305","author":"Chavanet","year":"1992","journal-title":"Br. Med. J."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0050","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1469-0691.1997.tb00282.x","article-title":"Toxicity and efficacy of conventional amphotericin B deoxycholate versus escalating doses of amphotericin B deoxycholate\u2014fat emulsion in HIV infected patients with oral candidasis","volume":"3","author":"Chavanet","year":"1997","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0055","first-page":"808","article-title":"Initial and long-term efficacy of a lipid emulsion of amphotericin B desoxycholate in the management of canine leishmaniasis","volume":"17","author":"Cortadellas","year":"2003","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/jac\/49.suppl_1.31","article-title":"Overview of the lipid formulations of amphotericin B","volume":"49","author":"Dupont","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0065","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/jac\/49.suppl_1.7","article-title":"Amphotericin B: spectrum and resistance","volume":"49","author":"Ellis","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0070","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1023\/A:1011096821662","article-title":"Relationship of pharmacokinetically-calculated volumes of distribution to the physiologic distribution of liposomal drugs in tissues: implications for the characterization of liposomal formulations","volume":"18","author":"Fielding","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0075","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1128\/AAC.36.2.299","article-title":"Relationship of pharmacokinetics and drug distribution in tissue to increased safety of amphotericin B colloidal dispersion in dogs","volume":"36","author":"Fielding","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0080","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/infdis\/156.5.784","article-title":"Induction of prostaglandin synthesis as the mechanism responsible for the chills and fever produced by infusing amphotericin","volume":"156","author":"Gigliotti","year":"1987","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0085","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1128\/AAC.01448-08","volume":"53","author":"Gubbins","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0090","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s40265-013-0069-4","article-title":"Amphotericin B formulations: a comparative review of efficacy and toxicity","volume":"73","author":"Hamill","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.rvsc.2017.12.005_bb0095","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF01059781","article-title":"Kinetic analysis of AUC-dependant saturable clearance of liposomes: mathematical description of AUC dependency","volume":"21","author":"Harashima","year":"1993","journal-title":"J. Pharmacokinet. Biopharm."},{"issue":"Suppl","key":"10.1016\/j.rvsc.2017.12.005_bb0100","first-page":"S8","article-title":"Pharmacokinetics of liposomal amphotericin B (AmBisome) versus other lipid-based formulations","volume":"14","author":"Heinemann","year":"1994","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0105","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1128\/AAC.41.6.1275","article-title":"Pharmacokinetics of liposomal amphotericin B (AmBisome) in critically III patients","volume":"41","author":"Heinemann","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0110","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1128\/AAC.26.4.446","article-title":"Comparative pharmacokinetics of Sch 28191 and amphotericin B in mice, rats, dogs, and cynomolgus monkeys","volume":"26","author":"Kim","year":"1984","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0115","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1748-5827.2001.tb01797.x","article-title":"Activity of amphotericin B in lipid emulsion in the initial treatment of canine leishmaniosis","volume":"42","author":"Lamothe","year":"2001","journal-title":"J. Small Anim. Pract."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0120","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.riam.2009.06.003","article-title":"Amphotericin B: side effects and toxicity","volume":"26","author":"Laniado-Labor\u00edn","year":"2009","journal-title":"Rev. Iberoam. Micol."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0125","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1128\/AAC.38.4.713","article-title":"Pharmacokinetics and safety of a unilamellar liposomal formulation of amphotericin B (AmBisome) in rabbits","volume":"38","author":"Lee","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0130","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1128\/AAC.01449-06","article-title":"Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis","volume":"51","author":"Lewis","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0135","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/jac\/30.4.535","article-title":"Reduced renal toxicity and improved clinical tolerance of amphotericin B mixed with intralipid compared with conventional amphotericin B in neutropenic patients","volume":"30","author":"Moreau","year":"1992","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0140","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1128\/AAC.43.6.1417","article-title":"Amphotericin B in children with malignant disease: a comparison of the toxicities and pharmacokinetics of amphotericin B administered in dextrose versus lipid emulsion","volume":"43","author":"Nath","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0145","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1128\/AAC.43.6.1445","article-title":"Comparison of the toxicity of amphotericin B in 5% dextrose with that of amphotericin B in fat emulsion in a randomized trial with cancer patients","volume":"43","author":"Nucci","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0150","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/jac\/38.1.154","article-title":"Efficacy and tolerance of amphotericin B in a lipid amulsion in the treatment of visceral leishmaniasis in AIDS patients","volume":"38","author":"Petit","year":"1996","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0155","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.2460\/ajvr.1996.57.07.1054","article-title":"Nephrotoxicity of amphotericin B administered to dogs in a fat emulsion versus five percent dextrose solution","volume":"57","author":"Randall","year":"1996","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0160","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1517\/17425247.5.7.805","article-title":"Drug delivery systems against leishmaniasis? Still an open question","volume":"5","author":"Romero","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0165","series-title":"The Merck Veterinary Manual","first-page":"2457","article-title":"Weight to body surface area conversion for dogs and cats","author":"Rosenthal","year":"1995"},{"key":"10.1016\/j.rvsc.2017.12.005_bb0170","first-page":"23","article-title":"Nephrotoxicity of amphotericin B in dogs: a comparison of two methods of administration","volume":"53","author":"Rubin","year":"1989","journal-title":"Can. J. Vet. Res."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0175","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/10611860400006596","article-title":"Amphotericin B molecular organization as an essential factor to improve activity\/toxicity ratio in the treatment of visceral leishmaniasis","volume":"12","author":"S\u00e1nchez-Brunete","year":"2004","journal-title":"J. Drug Target."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0180","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1093\/jac\/dks117","article-title":"Pharmacokinetics, tissue distribution and immunomodulatory effect of intralipid formulation of nystatin in mice","volume":"67","author":"Semis","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0190","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/jac\/44.6.787","article-title":"Antifungal activity of amphotericin B-lipid admixtures in experimental systemic candidosis in naive mice","volume":"44","author":"Shadkchan","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0195","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/jac\/48.2.245","article-title":"Treatment of experimental candidosis with amphotericin B-Intralipid admixtures in immunocompromised mice","volume":"48","author":"Shadkchan","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0200","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/mmy.41.1.15.19","article-title":"Pharmacokinetics of amphotericin B in serum and tissues in mice treated with amphotericin B-Intralipid","volume":"41","author":"Shadkchan","year":"2003","journal-title":"Med. Mycol."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0205","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/13693780310001624583","article-title":"Cytokines in mice treated with amphotericin B-Intralipid","volume":"42","author":"Shadkchan","year":"2004","journal-title":"Med. Mycol."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0210","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/jac\/39.5.655","article-title":"The use of commercially available lipid emulsions for the preparation of amphotericin B lipid admixtures","volume":"39","author":"Shadkhan","year":"1997","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0215","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3109\/13693786.2010.510539","article-title":"Differential transcriptional profiles induced by amphotericin B formulations on human monocytes during response to hyphae of aspergillus fumigatus","volume":"49","author":"Simitsopoulou","year":"2011","journal-title":"Med. Mycol."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0220","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0928-8244(03)00230-X","article-title":"Polyene and cytokine treatment of experimental aspergillosis","volume":"39","author":"Sionov","year":"2003","journal-title":"Immunol. Med. Microbiol."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0225","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/13693780310001598871","article-title":"Treatment of murine systemic aspergillosis with polyene-intralipid admixtures","volume":"42","author":"Sionov","year":"2004","journal-title":"Med. Mycol."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0230","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2885.2004.00605.x","article-title":"Plasma clearance","volume":"27","author":"Toutain","year":"2004","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0235","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1128\/AAC.45.3.679-685.2001","article-title":"Apoptosis contributes to amphotericin B induced nephrotoxicity","volume":"45","author":"Varlam","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0240","first-page":"124","article-title":"Recent advances in the understanding of drug-mediated infusion reactions and cytokine release syndrome","volume":"13","author":"Walker","year":"2010","journal-title":"Curr. Opin. Drug Disc."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0245","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0378-4347(92)80390-C","article-title":"High-performance liquid chromatographic analysis of amphotericin B in plasma, blood, urine and tissues for pharmacokinetic and tissues distribution studies","volume":"579","author":"Wang","year":"1992","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0250","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1023\/A:1016243313027","article-title":"Comparative tissue distribution and elimination of amphotericin B colloidal dispersion (Amphocil\u00ae) and Fungizone\u00ae after repeated dosing in rats","volume":"8","author":"Wang","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.rvsc.2017.12.005_bb0255","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1128\/AAC.50.2.469-473.2006","article-title":"Pharmacodynamic activity of amphotericin B deoxycholate is associated with peak plasma concentrations in a neutropenic murine model of invasive pulmonary aspergillosis","volume":"50","author":"Wiederhold","year":"2006","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Research in Veterinary Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034528817306872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034528817306872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T04:08:31Z","timestamp":1758514111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0034528817306872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":47,"alternative-id":["S0034528817306872"],"URL":"https:\/\/doi.org\/10.1016\/j.rvsc.2017.12.005","relation":{},"ISSN":["0034-5288"],"issn-type":[{"value":"0034-5288","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of conventional and lipid emulsion formulations of amphotericin B: Pharmacokinetics and toxicokinetics in dogs","name":"articletitle","label":"Article Title"},{"value":"Research in Veterinary Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rvsc.2017.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}